CNTO-0007

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCNTO-0007
Drug Alias Name42037788CNTO-0007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsInfarctionIschemiaStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsInfarctionIschemiaStroke

Other Information

ATC CodeN/A
Related LinksN/A